Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

There is a control SOC group with 60 pts and a treatment group of 60 pts with the SOC +Brilacidin.

THE FDA and others felt the study without SOC treatment for both groups was unethical. The Phase 3 study may have direct comparisons.

ACTI-6, a large trial with multiple repurposed drugs, has begun. It is possible Brilacidin will be a part of a future similar study if the phase 2 study is possible.

https://www.nih.gov/news-events/news-releases/large-clinical-trial-study-repurposed-drugs-treat-covid-19-symptoms.



GLTA Farrell